J&J Loses Around $24B in a Month: How to Play the Stock? [Yahoo! Finance]
Zimmer Biomet Holdings, Inc. (ZBH)
Last zimmer biomet holdings, inc. earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.zimmerbiomet.com
Company Research
Source: Yahoo! Finance
Though slowing sales in its MedTech segment, the upcoming patent expiration of its blockbuster drug, Stelara, and talc-related legal issues are hurting J&J, a lot of this stock price decline could be due to the broader drug/biotech sector decline in the past month. Lower-than-expected sales of Lilly LLY and Novo Nordisk 's NVO popular diabetes and obesity drugs in the third quarter, guidance cuts, pipeline setbacks and appointment of Robert F. Kennedy Jr., a vaccine skeptic, as head of Health and Human Services (HHS) have taken a toll on stocks in the large-cap pharma sector. The decline in J&J's share price and the drug/biotech sector's downturn in the past month have left investors wondering if they should sell J&J stock. Let's understand the company's strengths and weaknesses to better analyze how to play J&J stock following the latest dip. J&J's Innovative Medicine unit is performing at above-market levels. Its growth is being driven by existing products like Darzalex, Stelar
Show less
Read more
Impact Snapshot
Event Time:
ZBH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZBH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZBH alerts
High impacting Zimmer Biomet Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
ZBH
News
- Fresenius Kabi Submits 510(k) Notification for the Aurora Xi Plasmapheresis System Software Version 2.0 with New Nomogram [Yahoo! Finance]Yahoo! Finance
- SPR® Therapeutics Debuts New SPRINT® PNS Data for Low Back, Shoulder, Knee, and Headache at the 23rd Annual ASRA Pain Medicine Meeting [Yahoo! Finance]Yahoo! Finance
- Zimmer Biomet to Present at Citi's 2024 Global Healthcare ConferencePR Newswire
- Hexaware Launches QCaaS in Partnership with Archimedis Digital [Yahoo! Finance]Yahoo! Finance
- Molex Anticipates Steady Growth in High-Speed Connectivity in 2025, Driving Electronics Design Innovations Across Diverse Industry Sectors [Yahoo! Finance]Yahoo! Finance
ZBH
Earnings
- 10/30/24 - Miss
ZBH
Sec Filings
- 11/20/24 - Form 8-A12B
- 11/20/24 - Form 8-K
- 11/19/24 - Form 8-K
- ZBH's page on the SEC website